Document Detail


Hypertension in the elderly and the very old.
MedLine Citation:
PMID:  19505281     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
High systolic blood pressure represents a challenge for the modern world. Epidemiologists are in the best position to appreciate the importance of systolic hypertension and its cardiovascular consequences. Although the label of hypertension seems to have lower importance in the elderly, and above all in the very old, than in younger people, high systolic and high pulse pressure are risk factors for cardiovascular events and necessitates treatment. Unfortunately, due to indolence and lack of aggressiveness, only a limited fraction of elderly hypertensive patients receives adequate therapy.
Authors:
Edoardo Casiglia; Valérie Tikhonoff; Achille C Pessina
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Expert review of cardiovascular therapy     Volume:  7     ISSN:  1744-8344     ISO Abbreviation:  Expert Rev Cardiovasc Ther     Publication Date:  2009 Jun 
Date Detail:
Created Date:  2009-06-09     Completed Date:  2009-08-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101182328     Medline TA:  Expert Rev Cardiovasc Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  659-65     Citation Subset:  IM    
Affiliation:
Department of Clinical & Experimental Medicine, University of Padova, Via Giustiniani No. 2, Padova I-35128, Italy. edoardo.casiglia@unipd.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Age Factors
Aged
Aged, 80 and over
Antihypertensive Agents / therapeutic use
Blood Pressure / drug effects*
Cardiovascular Diseases / etiology*,  physiopathology
Humans
Hypertension / complications,  drug therapy*,  physiopathology
Risk Factors
Chemical
Reg. No./Substance:
0/Antihypertensive Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Concepts guiding therapy for hypertension in children.
Next Document:  Blocking the renin-angiotensin system: dual- versus mono-therapy.